Shareholders reject elevation of Joint MD and CFO to Managing Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.0 pts more than its Industrial Minerals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At the 40th Annual General Meeting held on September 30, 2026, shareholders of Southern Magnesium & Chemicals rejected the resolution to elevate Mr. Nuthakki Rajender Prasad from Joint Managing Director and CFO to Managing Director and CFO. Due to insufficient votes in favor, he will continue in his existing role as Joint Managing Director and CFO on the same terms. His current term runs from August 10, 2025 to August 9, 2028. The board had approved this change on November 12, 2025.
Leadership status quo continues. Promoter remains as Joint MD and CFO, no change in top management or designation.